Many employers have implemented a Centers of Excellence (COE) model in an effort to improve the quality of care for employees and reduce procedures caused by misdiagnoses and unnecessary treatment….
Read More
Health costs have soared over the past 30 years. Public and private employers have paid the majority of costs. In 2018, 158 million people in the US received their health…
Fast Health: Tampered Healthcare Costs By Managing Reversing Diabetes In the U.S., obesity and diabetes have been on the rise for generations. The health complications and long-term consequences have reverberated…
If U.S. healthcare costs were the GDP of a country in 2019, it could have ranked 5th in the world, behind Germany with a GDP of $3.8 trillion and ahead…
How can you prevent the Coronavirus from infecting you? Fortify yourself now with these five steps…
What’s the secret to a fulfilled and engaged workforce in the modern age? Three words: employee benefits consulting. For today’s workforce, employee benefits are the key to remaining competitive,...
Read More
Despite significant pressure from the federal government, PBMs are winning, while employers and patients are struggling to keep up with the increasing costs. In every other industry, innovation has led to the middle-man getting squeezed, yet in Pharmaceuticals, the PBM continues to grow more profitable and powerful each year.
The World Healthcare Congress in DC earlier this month was a phenomenal event, and I’ve shared a few key takeaways below. Employers are still facing significant challenges in finding their employees the right care, at the right price, at the right place; however, virtually all of these challenges have been and are being addressed by new, innovative vendors embracing proven strategies.
The HSA was launched in 2004 with great excitement from the employee benefits community. It was crafted with the intention of empowering consumers to make better healthcare decisions. And it’s been marketed as the only savings vehicle with “double tax benefits.”
